Growth, Pathogenesis, and Serological Characteristics of the Japanese Encephalitis Virus Genotype IV Recent Strain

Shigeru Tajima1, Takahiro Maeki1, Eri Nakayama1

  • 1Department of Virology 1, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo 162-8640, Japan.

Viruses
|January 21, 2023
PubMed

Insights

Genotype IV Japanese encephalitis virus (GIV JEV), a neglected strain, shows intermediate growth and varying neuroinvasiveness. Further research is needed to fully understand GIV JEV characteristics and its implications for Japanese encephalitis.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Genotype IV Japanese encephalitis virus (GIV JEV) is the least common and most neglected genotype.
  • Understanding GIV JEV's characteristics is crucial for disease control and vaccine development.

Purpose of the Study:

  • To evaluate the growth and pathogenic potential of the GIV strain 19CxBa-83-Cv isolated in Indonesia.
  • To conduct serological analyses of GIV JEV and its interaction with existing Japanese encephalitis virus (JEV) strains and vaccines.

Main Methods:

  • In vitro cell culture growth assays (Vero and mouse neuroblastoma cells).
  • In vivo mouse models to assess neuroinvasiveness and neurovirulence.
  • Serological analysis of neutralizing antibody titers against different JEV genotypes.

Main Results:

  • The GIV JEV strain 19CxBa-83-Cv exhibited intermediate growth in Vero cells and faster growth in mouse neuroblastoma cells compared to genotype V (GV) strain Muar.
  • Neuroinvasiveness of 19CxBa-83-Cv in mice was higher than genotype I (GI) strain Mie/41/2002 but lower than Muar; neurovirulence was similar across strains.
  • Neutralizing antibody titers varied, with lower responses against the GV strain Muar and reduced efficacy of JE vaccines against GIV JEV and GV strains compared to GI strain.

Conclusions:

  • The GIV JEV strain 19CxBa-83-Cv possesses distinct growth and pathogenic characteristics.
  • Current JE vaccines may have reduced efficacy against GIV JEV and GV strains, highlighting the need for updated or broader-spectrum vaccines.
  • Further research is essential to fully elucidate the epidemiology and public health impact of GIV JEV.

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...